Volume 11, Issue 2 (10-2023)
Jorjani Biomed J 2023, 11(2): 9-13 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Barzegari A A, Aghaee A, Shahabi K. Inhibitory effects of Echinophora platyloba L. ethanol extract on the development of morphine dependence: An in vivo study using naloxone-precipitated withdrawal symptoms in male mice. Jorjani Biomed J 2023; 11 (2) :9-13
URL: http://goums.ac.ir/jorjanijournal/article-1-968-en.html
URL: http://goums.ac.ir/jorjanijournal/article-1-968-en.html
1- Department of Biology, Faculty of Basic Science, University of Maragheh, Maragheh, Iran , barzegaridoctora@gmail.com
2- Department of Biology, Faculty of Basic Science, University of Maragheh, Maragheh, Iran
2- Department of Biology, Faculty of Basic Science, University of Maragheh, Maragheh, Iran
Abstract: (926 Views)
Background: Promising results were obtained by using medicinal plants for the treatment and prevention of opioid withdrawal syndrome. A native Iranian plant, Echinophora platyloba, has shown analgesic effects that may be mediated through opioid receptors. Thus, the present research evaluated the effects of the ethanolic extract of E. platyloba on the acquisition of morphine dependence in mice.
Methods: Thirty-two male mice were randomly allocated into four groups of eight. Morphine dependence was induced in the mice by subcutaneous administration of morphine (50, 50, and 75 mg/kg)×3 days, plus a single dose of morphine (50 mg/kg) on the fourth day. Withdrawal syndrome was precipitated by intraperitoneal injection of naloxone (4 mg/kg) 2 hours after the last dose of morphine. On days of dependence induction and before each morphine dose, the mice received intraperitoneal injections of saline (10 ml/kg) or plant extract (25, 50, and 75 mg/kg). After the injection of naloxone, the symptoms of withdrawal syndrome in each animal were monitored for 30 minutes.
Results: Administering morphine with this method induced morphine dependence in mice that were treated with saline before morphine. However, the mice that received the plant extract showed a significant decrease in the withdrawal symptoms including the number of jumping (P<0.01), rearing (P<0.05), grooming (P<0.05), and diarrhea (P<0.01) compared with the saline-treated mice.
Conclusion: Administration of the hydro-ethanolic extract of E. platyloba before morphine may inhibit the induction of morphine dependence. Therefore, the plant extract may be considered a therapeutic agent for the prevention of morphine dependence in morphine users.
Methods: Thirty-two male mice were randomly allocated into four groups of eight. Morphine dependence was induced in the mice by subcutaneous administration of morphine (50, 50, and 75 mg/kg)×3 days, plus a single dose of morphine (50 mg/kg) on the fourth day. Withdrawal syndrome was precipitated by intraperitoneal injection of naloxone (4 mg/kg) 2 hours after the last dose of morphine. On days of dependence induction and before each morphine dose, the mice received intraperitoneal injections of saline (10 ml/kg) or plant extract (25, 50, and 75 mg/kg). After the injection of naloxone, the symptoms of withdrawal syndrome in each animal were monitored for 30 minutes.
Results: Administering morphine with this method induced morphine dependence in mice that were treated with saline before morphine. However, the mice that received the plant extract showed a significant decrease in the withdrawal symptoms including the number of jumping (P<0.01), rearing (P<0.05), grooming (P<0.05), and diarrhea (P<0.01) compared with the saline-treated mice.
Conclusion: Administration of the hydro-ethanolic extract of E. platyloba before morphine may inhibit the induction of morphine dependence. Therefore, the plant extract may be considered a therapeutic agent for the prevention of morphine dependence in morphine users.
Type of Article: Original article |
Subject:
Basic Medical Sciences
Received: 2023/06/11 | Accepted: 2023/08/6 | Published: 2023/12/30
Received: 2023/06/11 | Accepted: 2023/08/6 | Published: 2023/12/30
References
1. Arzoun H, Srinivasan M, Sahib I, Fondeur J, Mendez LE, Hamouda RK, et al. Opioid use in patients with sickle cell disease during a vaso-occlusive crisis: a systematic review. Cureus. 2022;14(1):e21473. [view at publisher] [DOI] [PubMed] [Google Scholar]
2. Mercadante S, Adile C, Ferrera P, Pallotti MC, Ricci M, Bonanno G, et al. Methadone as first-line opioid for the management of cancer pain. Oncologist. 2022;27(4):323-7. [view at publisher] [DOI] [PMID] [Google Scholar]
3. Brozovich AA, Incavo SJ, Lambert BS, Sullivan TC, Wininger AE, Clyburn TA, et al. Intraosseous morphine decreases postoperative pain and pain medication use in total knee arthroplasty: a double-blind, randomized controlled trial. J Arthroplasty. 2022;37(6S):S139-46. [view at publisher] [DOI] [PMID] [Google Scholar]
4. Ganguly A, Michael M, Gorschin S, Harris K, McFarland D. Cancer Pain and Opioid Use Disorder. Oncology (Williston Park). 2022;36(9):535-41. [view at publisher] [DOI] [PubMed] [Google Scholar]
5. Lewis CE, Schutzer-Weissmann J, Farquhar-Smith P. Opioid use disorder in cancer patients. Curr Opin Support Palliat Care. 2023;17(2):98-103. [view at publisher] [DOI] [PMID] [Google Scholar]
6. Mercadante S, Arcuri E, Santoni A. Opioid-induced tolerance and hyperalgesia. CNS Drugs. 2019;33(10):943-55. [view at publisher] [DOI] [PMID] [Google Scholar]
7. Ternes JW, O'Brien CP. The opioids: abuse liability and treatments for dependence. Adv Alcohol Subst Abuse. 1990;9(1-2):27-45. [view at publisher] [DOI] [PMID] [Google Scholar]
8. Monroe SC, Radke AK. Opioid withdrawal: role in addiction and neural mechanisms. Psychopharmacology (Berl). 2023:240(7):1417-33. [view at publisher] [DOI] [PMID] [Google Scholar]
9. Kosten TR, Baxter LE. Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. Am J Addict. 2019;28(2):55-62. [view at publisher] [DOI] [PMID] [Google Scholar]
10. Van Andel T, Carvalheiro LG. Why urban citizens in developing countries use traditional medicines: the case of Suriname. Evid Based Complement Alternat Med. 2013;2013:687197. [view at publisher] [DOI] [PMID] [Google Scholar]
11. Karimi A, Majlesi M, Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 2015;4(1):27-30. [view at publisher] [DOI] [PubMed] [Google Scholar]
12. Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012;3(4):200-1. [view at publisher] [DOI] [PMID] [Google Scholar]
13. Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559. [view at publisher] [DOI] [PMID] [Google Scholar]
14. Nematollahi MH, Ahmadianmoghadam MA, Mehrabani M, Moghadari M, Ghorani-Azam A, Mehrbani M. Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials. Addict Health. 2022;14(2):152. [view at publisher] [DOI] [PubMed] [Google Scholar]
15. Bawa G, Mahajan R, Mehta M, Satija S, Vyas M, Sharma N, et al. Herbal drugs for the treatment of opioid withdrawal syndrome: A mini review. Plant Archives. 2019;19(2):1005-11. [view at publisher] [Google Scholar]
16. Raslan MA. Natural Products for the Treatment of Drug Addiction: Narrative Review. Chem Biodivers. 2022;19(12):e202200702. [view at publisher] [DOI] [PMID] [Google Scholar]
17. Hosseini Z, Lorigooini Z, Rafieian-Kopaei M, Shirmardi HA, Solati K. A review of botany and pharmacological effect and chemical composition of Echinophora species growing in Iran. Pharmacognosy Res. 2017;9(4):305-12. [view at publisher] [DOI] [PMID] [Google Scholar]
18. Anbari K, Abbaszadeh S, Basati G. Medicinal plants with preventive and therapeutic effect on diarrhoea: A cross-sectional epidemiologic and ethnobotanical study in traditional therapists of Shahrekord, south-west of Iran. Plant Science Today. 2019;6(4):512-7. [view at publisher] [DOI] [Google Scholar]
19. Kalantari M, Entezari M, Movafagh A, Hushmandi K, Dehghani H. Apoptotic Genes of Bax, Bad, Bcl2, and P53 in A549 Lung Cancer Cells Comparison of the Effect of Echinophora platyloba DC. Extract and Cordia myxa L Extract on the Expression of Apoptotic Genes of Bax, Bad, Bcl2, and P53 in A549 Lung Cancer Cells. Gulf J Oncolog. 2021;1(35):7-13. [view at publisher] [DOI] [PubMed] [Google Scholar]
20. Sharafati-chaleshtori R, Rafieian-kopaei M, Mortezaei S, Sharafati-chaleshtori A, Amini E. Antioxidant and antibacterial activity of the extracts of Echinophora platyloba DC. African Journal of Pharmacy and Pharmacology. 2012;6(37):2692-5. [view at publisher] [DOI] [Google Scholar]
21. Avijgan M, Mahboubi M, Nasab MM, Nia EA, Yousefi H. Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis. J Mycol Med. 2014;24(2):112-6. [view at publisher] [DOI] [PMID] [Google Scholar]
22. Avijgan M, Hafizi M, Saadat M, Nilforoushzadeh MA. Antifungal effect of Echinophora platyloba's extract against Candida albicans. Iranian J Pharmaceutical Research. 2006;4. [view at publisher] [DOI] [Google Scholar]
23. Avijgan M, Saadat M, Nilfrooshzadeh MA, Hafizi M. Anti fungal effect of Echinophora platyloba extract on some common dermathophytes. J Med Plants. 2006;5(18):10-6. [view at publisher] [DOI] [Google Scholar]
24. Asgari Nematian M, Mohammadi S. The analgesic effect of Echinophora platyloba hydroalcoholic extract in male rats. J Babol Univ Med Sci. 2016;18(5):31-7. [view at publisher] [DOI] [Google Scholar]
25. Asghari A, Kardooni M. Evaluation of wound healing activity of Echinophora platyloba extract on experimental full thickness skin wound in the rat. J Vet Clin Pathol. 2015;8(4):691-9. [view at publisher] [Google Scholar]
26. Sadraei H, Asghari G, Yaghobei K. Study of the effect of hydro-alcholic and essential oil of Echinophora platyloba on rat isolated ileum contractions in vitro. J Res Med Sci. 2002; 7(4):150-155. [view at publisher]
27. Delaram M, Kheiri S, Hodjati MR. Comparing the effects of Echinophora-platyloba, fennel and placebo on pre-menstrual syndrome. J Reprod Infertil. 2011;12(3):221-6. [view at publisher] [PubMed] [Google Scholar]
28. Ryu A, Kim T-H. Premenstrual syndrome: A mini review. Maturitas. 2015;82(4):436-40. [view at publisher] [DOI] [PMID] [Google Scholar]
29. Giannini AJ, Melemis SM, Martin DM, Folts DJ. Symptoms of premenstrual syndrome as a function of beta-endorphin: two subtypes. Prog Neuro-Psychopharmacol Biol Psychiatry. 1994;18(2):321-7. [view at publisher] [DOI] [PMID] [Google Scholar]
30. Giannini AJ, Price WA, Loiselle RH. β-Endorphin withdrawal: a possible cause of premenstrual tension syndrome. Int J Psychophysiol. 1984;1(4):341-3. [view at publisher] [DOI] [PMID] [Google Scholar]
31. Gudehithlu KP, Tehwani GA, Bhargava HN. β-Endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res. 1991;553(2):284-90. [view at publisher] [DOI] [PMID] [Google Scholar]
32. Reiss D, Maduna T, Maurin H, Audouard E, Gaveriaux‐Ruff C. Mu opioid receptor in microglia contributes to morphine analgesic tolerance,Extract of E. platyloba inhibits morphine dependence 13 hyperalgesia, and withdrawal in mice. J Neurosci Res. 2022;100(1):203-19. [view at publisher] [DOI] [PubMed] [Google Scholar]
33. Welsch L, Colantonio E, Falconnier C, Champagnol-DiLiberti C, Allain F, Hamida SB, et al. Mu opioid receptor-positive neurons in the dorsal raphe nucleus are impaired by morphine abstinence. Biol Psychiatry. 2023;S0006-3223(23)01397-5. [view at publisher] [DOI] [PubMed] [Google Scholar]
34. Sheikholeslami MA, Parvardeh S, Ghafghazi S, Sabetkasaei M. Curcumin attenuates morphine dependence by modulating μ-opioid receptors and glial cell-activated neuroinflammation in rat. Neuropeptides. 2023;98:102318. [view at publisher] [DOI] [PMID] [Google Scholar]
35. Abu Bakar NH, Hashim SN, Mohamad N, Husain R, Adnan LHM, Shariff H, et al. Role of oxidative stress in opiate withdrawal and dependence: Exploring the potential use of honey. Journal of Applied Pharmaceutical Science. 2015;5(12):159-61. [view at publisher] [DOI] [Google Scholar]
36. Ahmadianmoghadam MA, Nematollahi MH, Mehrabani M, Fatemi I, Rostamzadeh F, Dell'Agli M, et al. Effect of an herbal formulation containing Peganum harmala L. and Fraxinus excelsior L. on oxidative stress, memory impairment and withdrawal syndrome induced by morphine. Int J Neurosci. 2022:1-14. [view at publisher] [DOI] [PMID] [Google Scholar]
37. Ehsani A, Hashemi M, Afshari A. Antioxidant activity of Echinophora platyloba DC essential oil: a comparative study on four different methods. Iran J Veterinary Sci Technol. 2016;8(1):47-52. [view at publisher] [DOI] [Google Scholar]
38. Zarrindast MR, Malekzadeh A, Rezayat M, Ghazi‐Khansari M. Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice. Pharmacol toxicol. 1995;77(6):360-4. [view at publisher] [DOI] [PMID] [Google Scholar]
39. Pourmotabbed A, Rostamian B, Manouchehri G, Pirzadeh-Jahromi G, Sahraei H, Ghoshooni H, et al. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice. J Ethnopharmacol. 2004;95(2-3):431-5. [view at publisher] [DOI] [PMID] [Google Scholar]
40. Yayeh T, Yun K, Jang S, Oh S. Morphine dependence is attenuated by red ginseng extract and ginsenosides Rh2, Rg3, and compound K. J Ginseng Res. 2016;40(4):445-52. [view at publisher] [DOI] [PMID] [Google Scholar]
41. Barzegari AA, Shahabi K. Effects of Isoniazid on the Acquisition and Expression of Morphine Dependence in Male Mice. Pharm Biomed Res. 2021;7(4):279-88. [view at publisher] [DOI] [Google Scholar]
42. Hosseinzadeh H, Nourbakhsh M. Effect of Rosmarinus officinalis L. aerial parts extract on morphine withdrawal syndrome in mice. Phytother Res. 2003;17(8):938-41. [view at publisher] [DOI] [PMID] [Google Scholar]
43. Hosseinzadeh H, Lary P. Effect of Salvia leriifolia leaf extract on morphine dependence in mice. Phytother Res. 2000;14(5):384-7. [view at publisher] [DOI] [PMID] [Google Scholar]
44. Motaghinejad M, Bangash MY, Hosseini P, Karimian SM, Motaghinejad O. Attenuation of morphine withdrawal syndrome by various dosages of curcumin in comparison with clonidine in mouse: possible mechanism. Iran J Med Sci. 2015;40(2):125-32. [view at publisher] [PubMed] [Google Scholar]
45. Hadjmohammadi M, Karimiyan H, Sharifi V. Hollow fibre-based liquid phase microextraction combined with high-performance liquid chromatography for the analysis of flavonoids in Echinophora platyloba DC. and Mentha piperita. Food chem. 2013;141(2):731-5. [view at publisher] [DOI] [PMID] [Google Scholar]
46. Valizadeh H, Mahmoodi K, Alizadeh Z, Bahadori M. Isolation and structure elucidation of secondary metabolites from Echinophora platyloba DC from Iran. J Med Plants. 2014;13(49):15-21. [view at publisher] [DOI] [Google Scholar]
47. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 2001;81(1):299-343. [view at publisher] [DOI] [PMID] [Google Scholar]
48. Zhang M, Swarts SG, Yin L, Liu C, Tian Y, Cao Y, et al., editors. Antioxidant properties of quercetin. Adv Exp Med Biol. 2011;701:283-9. [view at publisher] [DOI] [PMID] [Google Scholar]
49. Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Amirgholami N, Houshmand G, Alboghobeish S. Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide. Metab Brain Dis. 2020;35(2):305-13. [view at publisher] [DOI] [PMID] [Google Scholar]
50. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167. [view at publisher] [DOI] [PMID] [Google Scholar]
51. Asgari Nematian M, Mohammadi S. The analgesic effect of Echinophora platyloba hydroalcoholic extract in male rats. J Babol Univ Med Sci. 2016;18(5):31-7. [view at publisher] [DOI] [PubMed] [Google Scholar]
52. Etemad L, Farkhari H, Alavi MS, Roohbakhsh A. The effect of dihydromyricetin, a natural flavonoid, on morphine-induced conditioned place preference and physical dependence in Mice. Drug Res (Stuttg). 2020;70(9):410-6. [view at publisher] [DOI] [PMID] [Google Scholar]
53. Naidu P, Singh A, Joshi D, Kulkarni S. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence. Addict biol. 2003;8(3):327-36. [view at publisher] [DOI] [PMID] [Google Scholar]
54. Akbarali H, Inkisar A, Dewey WL. Site and mechanism of morphine tolerance in the gastrointestinal tract. Neurogastroentrol Motil. 2014;26(10):1361-7. [view at publisher] [DOI] [PMID] [Google Scholar]
55. Liu W, Zhi A. The potential of Quercetin to protect against loperamide‐induced constipation in rats. Food Sci Nutr. 2021;9(6):3297-307. [view at publisher] [DOI] [PMID] [Google Scholar]
56. Kim JE, Lee MR, Park JJ, Choi JY, Song BR, Son HJ, et al. Quercetin promotes gastrointestinal motility and mucin secretion in loperamide-induced constipation of SD rats through regulation of the mAChRs downstream signal. Pharm biol. 2018;56(1):309-17. [view at publisher] [DOI] [PMID] [Google Scholar]
57. Tavani A, Bianchi G, Ferretti P, Manara L. Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action. Life Sci. 1980;27(23):2211-7. [view at publisher] [DOI] [PMID] [Google Scholar]
58. Bhargava HN, Way EL. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. Eur J Pharmacol. 1976;36(1):79-88. [view at publisher] [DOI] [PMID] [Google Scholar]
59. Listos J, Łupina M, Talarek S, Mazur A, Orzelska-Górka J, Kotlińska J. The mechanisms involved in morphine addiction: an overview. Int J Mol Sci. 2019;20(17):4302. [view at publisher] [DOI] [PMID] [Google Scholar]
60. Chen M, Yin Z, Zhang LY, Liao H. Quercetin promotes neurite growth through enhancing intracellular cAMP level and GAP-43 expression. Chin J Nat Med. 2015;13(9):667-72. [view at publisher] [DOI] [PMID] [Google Scholar]
61. Sturman O, Germain P-L, Bohacek J. Exploratory rearing: a context-and stress-sensitive behavior recorded in the open-field test. Stress. 2018;21(5):443-52. [view at publisher] [DOI] [PMID] [Google Scholar]
62. Kalueff AV, Tuohimaa P. Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs. Eur J Pharmacol. 2005;508(1-3):147-53. [view at publisher] [DOI] [PMID] [Google Scholar]
63. Jung JW, Lee S. Anxiolytic effects of quercetin: Involvement of GABAergic system. J Life Sci. 2014;24(3):290-6. [view at publisher] [DOI] [Google Scholar]
64. Ebrahimi B, Esmaeili-Mahani S. The Effects of Hydroalcoholic Extract of Satureja khuzestanica on Naloxone-Induced Morphine Withdrawal Symptoms in Wistar Rats. International Journal of Basic Science in Medicine. 2020;5(1):16-21. [view at publisher] [DOI] [Google Scholar]
65. Oleinichenko D, Ahn S, Song R, Snutch TP, Phillips AG. Morphine Withdrawal-Induced Hyperalgesia in Models of Acute and Extended Withdrawal Is Attenuated by l-Tetrahydropalmatine. Int J Mol Sci. 2023;24(10):8872. [view at publisher] [DOI] [PMID] [Google Scholar]
66. Kasraeifar S, Mokhtari-Zaer A, Marefati N, Rakhshandeh H, Hosseini M. Suppressive Effects of the Aerial Parts of Datura Stramonium L. Extract on Naloxone-Precipitated Morphine Withdrawal Signs in Mice. J Adv Med Biomed Res. 2022;30(143):561-5. [view at publisher] [DOI] [PubMed] [Google Scholar]
67. Yadav M, Parle M, Jindal DK, Dhingra S. Protective effects of stigmasterol against ketamine-induced psychotic symptoms: Possible behavioral, biochemical and histopathological changes in mice. Pharmacol Rep. 2018;70(3):591-9. [view at publisher] [DOI] [PMID] [Google Scholar]
68. Yin Y, Liu X, Liu J, Cai E, Zhao Y, Li H, et al. The effect of beta-sitosterol and its derivatives on depression by the modification of 5-HT, DA and GABA-ergic systems in mice. RSC adv. 2018;8(2):671-80. [view at publisher] [DOI] [PMID] [Google Scholar]
69. Lelevich S, Lelevich V, Novokshonov A. Neurotransmitter mechanisms of morphine withdrawal syndrome. Bull exp biol Med. 2009;148(2):184-7. [view at publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
